Tilray Inc (NASDAQ:TLRY – Get Free Report)’s stock price traded up 1.3% during trading on Tuesday . The company traded as high as $1.60 and last traded at $1.60. 4,121,774 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 24,889,479 shares. The stock had previously closed at $1.58.
Analyst Upgrades and Downgrades
Separately, Roth Mkm decreased their price target on Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a report on Friday, October 11th.
Get Our Latest Research Report on Tilray
Tilray Trading Up 7.9 %
Tilray (NASDAQ:TLRY – Get Free Report) last released its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, hitting the consensus estimate of ($0.04). Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The business had revenue of $200.00 million for the quarter, compared to analysts’ expectations of $218.70 million. During the same quarter in the previous year, the firm posted ($0.10) earnings per share. The company’s revenue was up 13.0% compared to the same quarter last year. On average, research analysts anticipate that Tilray Inc will post -0.14 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Tilray
Several hedge funds and other institutional investors have recently modified their holdings of TLRY. Tidal Investments LLC raised its stake in Tilray by 36,687.0% during the first quarter. Tidal Investments LLC now owns 10,677,428 shares of the company’s stock valued at $26,373,000 after buying an additional 10,648,403 shares in the last quarter. Bank of Montreal Can raised its holdings in shares of Tilray by 19.6% during the second quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock worth $3,622,000 after purchasing an additional 355,778 shares during the period. Virtu Financial LLC bought a new position in shares of Tilray in the 1st quarter worth about $586,000. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Tilray by 8.7% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company’s stock valued at $6,699,000 after buying an additional 213,834 shares during the last quarter. Finally, J.W. Cole Advisors Inc. lifted its holdings in Tilray by 1,077.2% in the second quarter. J.W. Cole Advisors Inc. now owns 171,054 shares of the company’s stock worth $284,000 after acquiring an additional 156,524 shares during the last quarter. Institutional investors own 9.35% of the company’s stock.
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Read More
- Five stocks we like better than Tilray
- Investing in Commodities: What Are They? How to Invest in Them
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Best Stocks Under $5.00
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.